Seres Therapeutics, Inc. (MCRB) — Analyst estimates
Consensus analyst estimates for Seres Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 12.50M | -1.63 | 1 |
| 2027 | 358K | -6.58 | 1 |
| 2028 | 358K | -11.41 | 1 |
| 2029 | 249.64K | -8.8 | 1 |
Consensus analyst estimates by fiscal year.